Vanguards of Healthcare by Bloomberg Intelligence

Transcarent’s Bet on AI and the End of Healthcare Scarcity

Sofinnova Partners Stays Optimistic on Biotech's Future

Transcarent’s Bet on AI and the End of Healthcare Scarcity

Smarter Technologies’ Blueprint for AI-Driven Revenue Cycle Management

Merck’s GHI Fund and the Push to Rewire Pharma's Future

Zymeworks on Rethinking Risk, Royalties and R&D

Penumbra Builds Clinical Support Showing Computer Assistance Can Better Address Clot

This is an episode of the "Vanguards of Health Care" series from Bloomberg Intelligence, featuring Matt Henriksson, a medical technology analyst, interviewing Adam Elsesser, CEO of Penumbra, a medical device company. They discuss Penumbra's computer-assisted vacuum thrombectomy (CAVT) technology, recent product launche...

Teva a Generic Giant With Biotech Bite

This podcast features Ann-Hunter van Kirk from Bloomberg Intelligence interviewing Eric Hughes, Executive Vice President of Global R&D and Chief Medical Officer at Teva Pharmaceuticals, about Teva's R&D, pipeline, and transformation from a generics company to an innovative powerhouse. They discuss the restructuring of ...

Aegis Ventures’ Blueprint for Building AI-Native Companies

In this episode of Bloomberg Intelligence's Vanguards of Health Care podcast, Jonathan Palmer interviews John Beadle, co-founder and managing partner of Aegis Ventures, a venture studio focused on digital health and AI. Beadle discusses Aegis's unique approach of co-founding companies with large health systems to solve...

Beta Bionics Does the Work to Reduce Insulin Pump Burden

This podcast features Matt Henriksson from Bloomberg Intelligence interviewing Sean Saint, CEO of Beta Bionics, about automated insulin delivery systems. They discuss Sean's background in the diabetes technology industry, the evolution of insulin delivery methods, and the unique features of Beta Bionics' iLet pump, inc...

Fosun Pharma’s Drive Beyond China

ARS Pharma’s Clinical Differentiation

Biolinq Introduces New Silicon Tech Opens Next Chapter of Glucose and Analyte Detection

Recapping ESMO, Inside AstraZeneca’s Bold Bet on Antibody Drug Conjugates

This podcast features Sam Fazeli, a Senior Pharmaceutical Analyst, interviewing Dr. Susan Galbraith, Executive Vice President of Oncology R&D at AstraZeneca, about data presented at the European Society for Medical Oncology (ESMO) conference. They discuss AstraZeneca's data in breast cancer, focusing on early intervent...

Synchron Can Provide Brain Computer Interface Tech Without the Brain Surgery

In this episode of the Vanguards of Health Care series, Matt Henriksson interviews Tom Oxley, founder and CEO of Synchron, about brain-computer interface (BCI) technology. Oxley discusses his career path, the evolution of neuro-intervention, and the potential of BCI to unlock a data economy within the brain. The conver...

Honor Utilizing AI to Scale Home Care, Kinking the Quality Curve Higher

In this episode of Bloomberg Intelligence's Vanguards of Health Care podcast, Jonathan Palmer interviews Seth Sternberg, CEO and co-founder of Honor Technology and Home Instead, about his mission to change how society cares for older adults. Sternberg discusses his initial focus on hardware devices before pivoting to n...

Orthofix Builds Specialized Portfolio for the Toughest Ortho and Spine Cases

The "Vanguards of Health Care" podcast features Matt Henriksson from Bloomberg Intelligence interviewing Massimo Calafiore, CEO of Orthofix, a medical device company. Calafiore discusses his career path, what attracted him to Orthofix, and the changes he's implemented, including building a team of experts. The conversa...

Onward Medical Revives Hope for SCI

This podcast features Matt Henriksson from Bloomberg Intelligence interviewing Dave Marver, CEO of Onward Medical, about the company's progress in developing therapies for spinal cord injuries. They discuss Onward's three technology platforms: ARC-EX, ARC-IM, and ARC-BCI, focusing on the recent de novo approval and com...

Viz.ai Taps Artificial Intelligence to Accelerate Point-of-Care Decisions

In this episode of the "Vanguards of Health Care" series, Matt Henriksson interviews Chris Mansi, the founder and CEO of Viz.ai, and Frank Defesche, the SVP and general manager of Salesforce Life Sciences. Chris discusses his background as a neurosurgeon and the pivotal experience that led him to create Viz.ai, an AI-d...

Inside Exact Science’s Next Big Bet - One Blood Draw, More than 50 Cancers

This podcast features Jonathan Palmer from Bloomberg Intelligence interviewing Kevin Conroy, CEO of Exact Sciences, a leader in cancer diagnostics. They discuss the evolution of Exact Sciences from its early days to its current status, highlighting key milestones such as the development and launch of Cologuard. The con...